2024 Fall Conference | Industry Therapeutic Update from Biogen: SKYCLARYS® (omaveloxolone) The First and Only FDA-Approved Prescription Treatment for Friedreich Ataxia in Adults and Adolescents Aged 16 Years and Older
07:00 AM - 07:50 AM PDT | Speaker |
Industry Therapeutic Update from Biogen: SKYCLARYS® (omaveloxolone) The First and Only FDA-Approved Prescription Treatment for Friedreich Ataxia in Adults and Adolescents Aged 16 Years and Older
|